Alkeus Pharmaceuticals, Inc. is a clinical-stage biotech company focused on the development of innovative therapies to treat serious diseases of the eye with high unmet need. Based in Cambridge, Mass., Alkeus was founded in 2010, and since that time has been developing its lead compound, gildeuretinol acetate (ALK-001). Designated as a breakthrough therapy and granted orphan drug status by the U.S. Food and Drug Administration, gildeuretinol is being evaluated in multiple clinical trials for the treatment of Stargardt disease and geographic atrophy (GA) secondary to age-related macular degeneration (AMD), a leading cause of blindness in the U.S. We are seeking a highly motivated and collaborative physician to join our Clinical Development team as Medical Director. Position Summary The Medical Director will play a key role in the medical oversight and execution of clinical trials supporting the development of therapies for retinal diseases, with primary responsibility for the company’s Phase 3 clinical program and additional contributions to ongoing Phase 2 trials. Working closely with the Vice President of Clinical Development and the broader cross-functional development team, the Medical Director will provide medical and scientific leadership across clinical trial design, execution, safety oversight, and interpretation of clinical data. This individual will collaborate closely with clinical operations, biostatistics, regulatory affairs, pharmacovigilance, and medical affairs to ensure the successful conduct of high-quality clinical studies aligned with regulatory expectations and company strategy.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
Ph.D. or professional degree